[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/19, MON) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 AZ, 인시트로 ‘MASH·심근병증’ AI 신약개발 15억弗 딜
[https://www.biospectator.com/news/view/30106](https://www.biospectator.com/news/view/30106)

 HLB ‘리픽투’, FDA 가속 아닌 “정식승인 가능했던” 까닭
[https://www.biospectator.com/news/view/30114](https://www.biospectator.com/news/view/30114)

 GC셀 美관계사 아티바, 'NK세포' 자가면역 "ACR 발표”
[https://www.biospectator.com/news/view/30096](https://www.biospectator.com/news/view/30096)

 Vetter, 新주사기 밀폐 'V-OVS next' 레드닷어워드 수상
[https://www.biospectator.com/news/view/30112](https://www.biospectator.com/news/view/30112)

 에이비엘, '4-1BB 이중항체' 2개 에셋 1상 "ESMO 공개"
[https://www.biospectator.com/news/view/30118](https://www.biospectator.com/news/view/30118)

 삼성바이오, 월드ADC 참가.."ADC 서비스 역량 알려"
[https://www.biospectator.com/news/view/30115](https://www.biospectator.com/news/view/30115)

 큐리언트, 'CDK7 저해제' 고형암 1상 "ESMO 공개"
[https://www.biospectator.com/news/view/30116](https://www.biospectator.com/news/view/30116)

 에이비스, '의료AI 지원사업' 현장서 "IHC 솔루션 시연"
[https://www.biospectator.com/news/view/30119](https://www.biospectator.com/news/view/30119)

 베라스템, 'KRAS G12D' 췌장암 1/2상 "ORR 50%" 
[https://www.biospectator.com/news/view/30120](https://www.biospectator.com/news/view/30120)

 지투지바이오, 中UBT과 '지속형 플랫폼' 평가계약 
[https://www.biospectator.com/news/view/30122](https://www.biospectator.com/news/view/30122)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/19, MON) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)